Penile rehabilitation with low-intensity extracorporeal shock wave therapy in patients after prostate cancer surgery. Early physiological changes and postoperative follow-up outcomes.
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
30
08
2021
received:
07
07
2021
accepted:
31
08
2021
pubmed:
7
9
2021
medline:
1
1
2022
entrez:
6
9
2021
Statut:
ppublish
Résumé
To investigate the efficacy, safety and postoperative outcomes of using tadalafil and low-intensity extracorporeal shock wave therapy (Li-ESWT) on penile rehabilitation and preventing urinary incontinence after radical prostatectomy. In total, we included 66 patients who used only tadalafil (n = 32) in group 1 and used tadalafil and treated by Li-ESWT (n = 34) in group 2. We noted International Index of Erectile Function (IIEF) 5, daily incontinence pad measurements at preoperative, postoperative 3rd, 6th and 12th months respectively. We also evaluated penis blood flow and neovascularisation by penile doppler ultrasonography at postoperative 3rd and 12th months for all patients. Statistical analyses were performed with SPSS version 18. A P-value < .05 was considered significant. Preoperative demographic characteristics were similar in the two groups. There was a statistically significant improvement in IIEF-5, which started at the 6th month and continued increasingly at the 12th month in group 2 compared with group 1. Also, there was a significant decrease in incontinence rate in group 2 compared with group 1 in the sixth month. Combined use of tadalafil and Li-ESWT is highly effective and safe for the treatment of erectile dysfunction and for the prevention of urinary incontinence after prostate cancer surgery.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14804Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Karakose A, Alp T, Güner ND, et al. The place of andrological cases in our general urology practice. Turk J Urol. 2010;36:49-54.
Liu C, Lopez DS, Chen M, et al. Penile rehabilitation therapy following radical prostatectomy: a meta-analysis. J Sex Med. 2017;14:1496-1503.
Karakose A, Yüksel MB, Aydogdu O, et al. The effect of bisphosphonates on bone mineral density in metastatic prostate cancer patients who are treated with anti-androgen drugs and radiotherapy. Curr Urol. 2014;7:181-184
Usta MF, Gabrielson AT, Bivalacqua TJ. Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction following radical prostatectomy: a critical review Your Sexual Medicine Journal. Int J Impot Res. 2019;31:231-238.
Aydogdu O, Gokce MI, Burgu B, et al. Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy. Int Braz J Urol. 2011;37:336-346.
Vignozzi L, Filippi S, Morelli A, et al. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med. 2006;3:419-431.
Karakose A, Alp T, Guner ND, et al. The role of Doppler ultrasonography and resistive index in the diagnosis and treatment of benign prostate hyperplasia. Turk J Urol. 2010;36:292-297.
Zou Z-J, Liang J-Y, Liu Z-H, et al. Low-intensity extracorporeal shock wave therapy for erectile dysfunction after radical prostatectomy: a review of preclinical studies. Int J Impot Res. 2018;30:1-7.
Zhang D, Wang Y-L, Gong D-X, et al. Radial extracorporeal shock wave therapy as a novel agent for benign prostatic hyperplasia refractory to current medical therapy. Am J Mens Health. 2019;13:1557988319831899.
Lei H, Liu J, Li H, et al. Low-intensity shock wave therapy and its application to erectile dysfunction. World J Mens Health. 2013;31:208-214.
Krhut J, Zachoval R, Smith PP, et al. Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn. 2014;33(5):507-510.
Aydogdu O, Atesci YZ, Karakose A, et al. Benign phyllodes tumour of the prostate: an extremely rare entity. Can Urol Assoc J. 2014;8:548-551.
Checcucci E, Amparore D, De Luca S, et al. Precision prostate cancer surgery: an overview of new technologies and techniques. Minerva Urol Nefrol. 2019;71:487-501.
Montorsi F, Luigi GG, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997;158:1408-1410.
Padma-Nathan H, McCullough AR, Levine LA, et al. Study Group. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res. 2008;20:479-486.
Kendircia M, Bejmab J, Hellstromc WJ. Update on erectile dysfunction in prostate cancer patients. Curr Opin Urol. 2006;16:186-195.
Karakose A, Yüksel MB. The relationships between waist circumference as an indicator of central obesity and lower urinary tract symptoms, erectile dysfunction and metabolic syndrome components. Dicle Med J. 2012;39(4):504-508.
Marchioni M, De Francesco P, Castellucci R, et al. Management of erectile dysfunction following robot-assisted radical prostatectomy: a systematic review. Minerva Urol Nefrol. 2020;72(5):543-554.
Yuan P, Ma D, Zhang Y, et al. Efficacy of low-intensity extracorporeal shock wave therapy for the treatment of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Neurourol Urodyn. 2019;38(6):1457-1466.
Vardi Y, Appel B, Jacob G, et al. Can low-ıntensity extracorporeal shockwave therapy ımprove erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010;58:243-248.
Capogrosso P, Salonia A, Briganti A, et al. Postprostatectomy erectile dysfunction: a review. World J Mens Health. 2016;34:73-88.
Weyne E, Mulhall J, Albersen M. Molecular pathophysiology of cavernous nerve injury and identification of strategies for nerve function recovery after radical prostatectomy. Curr Drug Targets. 2015;16:459-473.
Karakose A, Aydogdu O, Atesci YZ. Clinical comparison of two new minimally invasive techniques in the treatment of benign prostatic hyperplasia: Twister™ Diode Laser System vs. BiVap (Richard Wolf®) saline vaporization of the prostate. Minerva Urol Nefrol. 2015;67:355-363.
Jo JK, Jeong SJ, Oh JJ, et al. Effect of starting penile rehabilitation with sildenafil immediately after robot-assisted laparoscopic radical prostatectomy on erectile function recovery: a prospective randomized trial. J Urol. 2018;199:1600-1606.
Karakose A. Clinical comparison of two minimal invasive techniques in the treatment of benign prostatic enlargement over 90 ml: BIVAP (Richard Wolf®) saline vaporization of the prostate vs. bipolar plasmakinetic TURP. Arch Esp Urol. 2020;73:140-146.
Porpiglia F, Manfredi M, Checcucci E, et al. Use of chitosan membranes after nerve-sparing radical prostatectomy improves early recovery of sexual potency: results of a comparative study. BJU Int. 2019;123:465-473.
Qin F, Wang S, Li J, et al. The early use of vacuum therapy for penile rehabilitation after radical prostatectomy: systematic review and meta-analysis. Am J Mens Health. 2018;12:2136-2143.
Ateşçi YZ, Aydoğdu Ö, Karaköse A, et al. Does urinary bladder shape affect urinary flow rate in men with lower urinary tract symptoms? Sci World J. 2014;2014:846856.
Lee Y-C, Chuang S-M, Lin K-L, et al. Low-intensity extracorporeal shock wave therapy ameliorates the overactive bladder: a prospective pilot study. Biomed Res Int. 2020;2020:9175676.
Manfredi M, Fiori C, Peretti D, et al. Laparoscopic simple prostatectomy: complications and functional results after five years of follow-up. Minerva Urol Nefrol. 2020;72:498-504.